Literature DB >> 25693054

Microglia and neuroprotection.

Zhihong Chen1, Bruce D Trapp1.   

Abstract

Microglia were first identified over a century ago, but our knowledge about their ontogeny and functions has significantly expanded only recently. Microglia colonize the central nervous system (CNS) in utero and play essential roles in brain development. Once neural development is completed, microglia function as the resident innate immune cells of the CNS by surveying their microenvironment and becoming activated when the CNS is challenged by infection, injury, or disease. Despite the traditional view of microglia as being destructive in neurological diseases, recent studies have shown that microglia maintain CNS homeostasis and protect the CNS under various pathological conditions. Microglia can be prophylactically activated by modeling infection with systemic lipopolysaccharide injections and these activated microglia can protect the brain from traumatic injury through modulation of neuronal synapses. Microglia can also protect the CNS by promoting neurogenesis, clearing debris, and suppressing inflammation in diseases such as stroke, autism, and Alzheimer's. Microglia are the resident innate immune cells of the CNS. Despite the traditional view of microglia as being destructive in neurological diseases, recent studies have shown that they maintain tissue homeostasis and protect the CNS under various pathological conditions. They achieve so by clearing debris, promoting neurogenesis, suppressing inflammation and stripping inhibitory synapses. This review summarizes recent advances of our understanding on the multi-dimensional neuroprotective roles of microglia.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  M2-like; microglia; neuroprotection; phagocytosis; synaptic stripping

Mesh:

Year:  2015        PMID: 25693054     DOI: 10.1111/jnc.13062

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  107 in total

Review 1.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

Review 3.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

4.  Plasma metabolic profiling analysis of neurotoxicity induced by oxaliplatin using metabonomics and multivariate data analysis.

Authors:  Yanyan Xu; Yiwei Zhao; Xuejun Guo; Yubo Li; Yanjun Zhang
Journal:  Toxicol Res (Camb)       Date:  2018-04-27       Impact factor: 3.524

Review 5.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

6.  Minocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.

Authors:  J Alex Strahan; William H Walker; Taylor R Montgomery; Nancy G Forger
Journal:  Dev Neurobiol       Date:  2016-10-14       Impact factor: 3.964

7.  Ginkgolide B Protects Against Ischemic Stroke Via Modulating Microglia Polarization in Mice.

Authors:  Zhao-Ma Shu; Xiao-Dong Shu; Hui-Qin Li; Yi Sun; Han Shan; Xi-Yang Sun; Ren-Hong Du; Ming Lu; Ming Xiao; Jian-Hua Ding; Gang Hu
Journal:  CNS Neurosci Ther       Date:  2016-06-16       Impact factor: 5.243

8.  Microglial responses after phagocytosis: Escherichia coli bioparticles, but not cell debris or amyloid beta, induce matrix metalloproteinase-9 secretion in cultured rat primary microglial cells.

Authors:  Gen Hamanaka; Tomoya Kubo; Ryo Ohtomo; Hajime Takase; Estefania Reyes-Bricio; Shuntaro Oribe; Noriko Osumi; Josephine Lok; Eng H Lo; Ken Arai
Journal:  Glia       Date:  2020-02-14       Impact factor: 7.452

9.  Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.

Authors:  Kota Kurisu; Zhen Zheng; Jong Youl Kim; Jian Shi; Atsushi Kanoke; Jialing Liu; Christine L Hsieh; Midori A Yenari
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-07       Impact factor: 6.200

10.  Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.

Authors:  Grace Y Sun; Runting Li; Jiankun Cui; Mark Hannink; Zezong Gu; Kevin L Fritsche; Dennis B Lubahn; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2016-05-21       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.